|
|
 | | | |
- close
- close
- close
- close
| |||||||||
These excerpts taken from the CHRS 10-K filed Apr 1, 2009. Long-term
Debt” and “Item 8. Financial
Statements and Supplementary Data; Notes to Consolidated Financial Statements;
NOTE
8. LONG-TERM DEBT” below).
Information
regarding our equity compensation plans appears in Long-term Debt” and “Item 8. Financial Statements and Supplementary Data; Notes to Consolidated Financial Statements; NOTE 8. LONG-TERM DEBT” below). Information regarding our equity compensation plans appears in These excerpts taken from the CHRS 10-K filed Apr 2, 2008. Long-term
Debt
On April
30, 2007 we issued $250.0 million in aggregate principal amount of 1.125% Senior
Convertible Notes due May 1, 2014 (the “1.125% Notes”) in a private offering for
resale to qualified institutional buyers pursuant to Rule 144A under the
Securities Act of 1933, as amended. On May 11, 2007 the initial
purchasers of the 1.125% Notes exercised their over-allotment option and
purchased an additional $25.0 million in principal amount of
notes. The 1.125% Notes were issued at par, and interest is payable
semiannually in arrears on May 1 and November 1, beginning November 1,
2007. The 1.125% Notes will mature on May 1, 2014, unless earlier
repurchased by us or converted.
We
received proceeds of approximately $268.1 million from the issuance, net of
underwriting fees of approximately $6.9 million. The underwriting
fees, as well as additional transaction costs of $0.7 million incurred in
connection with the issuance of the 1.125% Notes, are included in “Other
assets,” and amortized to interest expense on an effective interest rate basis
over the remaining life of the notes (seven years).
On April
30, 2007 we called for the redemption on June 4, 2007 of our $149.999 million
outstanding aggregate principal amount of 4.75% Senior Convertible Notes due
June 1, 2012 (the “4.75% Notes”). The holders of the 4.75% Notes had
the option to convert their notes into shares of our common stock at a
conversion price of $9.88 per share until the close of business on June 1,
2007. As of June 4, 2007, the holders of $149.956 million principal
amount of the 4.75% Notes had exercised their right to convert their notes into
an aggregate of 15.146 million shares of our common stock and the remaining
notes were redeemed for $43 thousand. In addition, we paid $392
thousand in lieu of fractional shares.
Additional
information regarding our short-term and long-term borrowings is included in
Long-term Debt On April 30, 2007 we issued $250.0 million in aggregate principal amount of 1.125% Senior Convertible Notes due May 1, 2014 (the “1.125% Notes”) in a private offering for resale to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. On May 11, 2007 the initial purchasers of the 1.125% Notes exercised their over-allotment option and purchased an additional $25.0 million in principal amount of notes. The 1.125% Notes were issued at par, and interest is payable semiannually in arrears on May 1 and November 1, beginning November 1, 2007. The 1.125% Notes will mature on May 1, 2014, unless earlier repurchased by us or converted. We received proceeds of approximately $268.1 million from the issuance, net of underwriting fees of approximately $6.9 million. The underwriting fees, as well as additional transaction costs of $0.7 million incurred in connection with the issuance of the 1.125% Notes, are included in “Other assets,” and amortized to interest expense on an effective interest rate basis over the remaining life of the notes (seven years). On April 30, 2007 we called for the redemption on June 4, 2007 of our $149.999 million outstanding aggregate principal amount of 4.75% Senior Convertible Notes due June 1, 2012 (the “4.75% Notes”). The holders of the 4.75% Notes had the option to convert their notes into shares of our common stock at a conversion price of $9.88 per share until the close of business on June 1, 2007. As of June 4, 2007, the holders of $149.956 million principal amount of the 4.75% Notes had exercised their right to convert their notes into an aggregate of 15.146 million shares of our common stock and the remaining notes were redeemed for $43 thousand. In addition, we paid $392 thousand in lieu of fractional shares. Additional information regarding our short-term and long-term borrowings is included in | EXCERPTS ON THIS PAGE:
|
| |||||||
